|
1 Berg AH, Combs TP, Scherer PE, et al. ACRP30/adiponectin: An adipokiner egulating glucose and lipid metabolism[J]. Trends Endocrinol Metab, 2002, 13(2): 84-89.
|
|
2 Hu YM, Jiang ZF, ed. Zhu Futang Practical Pediatrics. 7 th ed[M]. Beijing: People's Medical Publishing House, 2002, 552-553. [胡亚美,江载芳,编著. 诸福棠实用儿科学.7版[M]. 北京:人民卫生出版社,2002, 552-553.]
|
|
3 Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association.Diagnostic criteria of nonalcoholic fatty liver disease[J].Chin J Hepatol, 2003, 11(2): 71.[中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊断标准[J]. 中华肝脏病杂志,2003, 11(2): 71.]
|
|
4 Shand BI, Scott RS, Elder PA, et al. Plasma adiponectin in over weight, nondiabetic individuals with or without insulin resistance[J]. Diabetes Obes Metab, 2003, 5(5): 349-353.
|
|
5 Fortuno A, Rodriguez A, Gomez AJ, et al. Adipose tissue as an endocrineorgan: Role of leptin and adiponectin in the pathogenesis of cardiovascular diseases[J]. J Physiol Biochem, 2003, 59(1): 51-60.
|
|
6 Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type2 diabetes: Close as sociation with insulin resistance and hyperinsulinemia[J]. J Clin Endocrinol Metab, 2001, 86(5): 1930-1935.
|
|
7 Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increased plasma level sofana adipose derived anti-inflammatory protein, adiponectin[J]. J Clin Endocrinol Metab, 2001, 86(8): 3815-3819.
|
|
8 Asayama K, Hayashibe H, Dobashi K, et al. Decrease in serum adiponectin level due to obesity and viseral fat accumulation in children[J]. Obes Res, 2003, 11(9): 1072-1079.
|
|
9 Nemet D, Wang P, Funahashi T, et al. Adipocytokines, body composition, and fitness in children[J]. Pediatr Res, 2003, 53(1): 148-152.
|
|
10 Norberts S, Joy C, Arlined D, et al. Plasma adiponectin concentrations in children: Relationships with obesity and nsulinemia[J]. J Clin Endocrinol Metab, 2002,87(10): 4652-4656.
|
|
11 Yan WJ, Wu J, Mo J, et al. Plasma levels of adiponectin and tumor necrosis factor-alpha in children with obesity[J]. Chin J Contemp Pediatr, 2009, 11(1): 47-50. [颜伟健,吴静,莫娟,等.肥胖儿童血浆脂联素与肿瘤坏死因子-α的变化及意义[J] .中国当代儿科杂志,2009, 11(1): 47-50.]
|
|
12 Wang YN, Tong FZ, Chang B, et al. Correlation of adiponectin and lipid in children with obesity [J]. Chin J Pract Pediatr, 2006, 21(10): 777-778. [王云宁,佟风芝,常波,等. 肥胖儿童脂联素和血脂检测及其相关性[J].中国实用儿科杂志,2006, 21(10): 777-778.]
|
|
13 Shuldiner AR, Yang R, Gong DW. Resistin, obesity,and insulin resistance: The emerging role of the adipocyte as an endocrineorgan[J]. N Engl J Med, 2001, 345(18): 1345-1346.
|
|
14 Fan JG, Zeng MD, Li JQ, et al. Analysis of risk factors of fatty liver[J]. Chin J Prev Med, 1998, 32(3): 189. [范建高,曾民德,李继强,等.脂肪肝的危险因素分析[J]. 中华预防医学杂志,1998, 32(3): 189.]
|
|
15 Harrison SA, Di Bisceglie AM. Advances in the understanding and treatment of nonalcoholic fatty liver disease[J]. Drugs, 2003, 63(22): 2279-2294.
|
|
16 Reinehr T, Roth C, Menke T, et al. Adiponectin before and after weight loss in obese children [J]. J Clin Endocrinol Metab, 89(8): 3790-3794,
|